Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2019 Earnings Conference Call - Final Transcript
Aug 13, 2019 • 04:30 pm ET
Mark C. Capone
because frankly it's mind-numbingly complex on whatever payers may have in their particular contract. So it's not a detail that we actually go into.
Okay. Thank you.
There are no further questions. I'll turn the call back to you.
Thank you, Kevin. This concludes our earnings call for today. A replay will be available will via webcast on our website for one week. Thank you again for joining us this afternoon.
[Operator Closing Remarks]